Source: Annual Congress 2004 - Trauma, interstitial disease and miscellaneous
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. P. Molodtsova, V. A. Gerasin (St Petersburg, Russia). Undifferentiated or "chronic" foreign bodies of bronchi as the reason of inflammatory lung diseases. Eur Respir J 2004; 24: Suppl. 48, 1103

Member's Comments

No comment yet.

Related content which might interest you: Neutrophils in chronic inflammatory airway diseases: can we target them and how? Source: Eur Respir J 2010; 35: 467-469 Year: 2010 ¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 How to treat bronchial granuloma in chronic granulomatous disease? Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 Small airways diseases, excluding asthma and COPD: an overview Source: Eur Respir Rev 2013; 22: 131-147 Year: 2013 Characteristics of inflammatory bowel diseases-associated interstitial lung diseases Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Rare interstitial lung diseases of environmental origin Source: Eur Respir Mon 2011; 54: 301-316 Year: 2011 Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling? Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 "Nitosative stress" in the bronchial mucosa of severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 363s Year: 2005 Smoking-related interstitial lung diseases: a concise review Source: Eur Respir J 2001; 17: 122-132 Year: 2001 Tele-rehabilitation in chronic lung diseases Source: ERS Course 2017 Year: 2017 "Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease" Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Rare interstitial lung diseases Source: School Course 2014 - Interstitial lung diseases Year: 2014 The role of macrophages in interstitial lung diseases Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017 Year: 2017 An integrated approach in the diagnosis of smoking-related interstitial lung diseases Source: Eur Respir Rev 2012 21:207-217 Year: 2012 Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities? Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Diffuse parenchymal lung diseases Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Diffuse parenchymal lung diseases Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Diffuse parenchymal lung diseases Source: ERS Skills Course 2016 Year: 2016